Oncogenic BRAF mutations have been detected in approximately 6% of human cancers, with most occurring in hairy cell leukemia (> 97%), melanoma (40–50%), thyroid cancer (30–50%), colorectal cancer (10%), and non-small cell lung cancer (3–5%) [5]. This evidence concerns the gene BRAF and thyroid gland carcinoma.